18 Jun 2009 07:00
ο»Ώ
18thΒ June 2008
Jelf Group plc
('Jelf' or 'Jelf Group' or 'The Group')
Interim Results for the six months ended 31 March 2009
JELF CONTINUED GROWTH
Jelf Group plc, a leading independent corporate consultancy providingΒ advice on insurance,Β employee benefits including healthcare, commercial finance and wealth management, today announces its interim results for the six months ended 31 March 2009.Β
FINANCIAL HIGHLIGHTS
40% growth in Revenue to Β£35.0m (2008: Β£25.0m)
11% growth in EBITDAE to Β£3.5m (2008: Β£3.1m)
5% organic revenue growth in Employee BenefitsΒ
Cash generated from operations of Β£8.3m (2008: Β£6.5m)Β
10%Β EBITDAEΒ marginΒ (2008:Β 12%)
OPERATING HIGHLIGHTS
Growth continues,Β
Good cross sales through existing client relationshipsΒ and major acquisitions
Integration of major acquisitions made in 2008 going to plan
Investment in people and systems continues
Focus on costs has achieved results but there is more to be doneΒ as the economic downturn continues
Award of 2* (Outstanding) Investors In Customers from (IIC)
Alex Alway, Group Chief Executive, said:
"Market conditions remain extremely difficultΒ and I do not expect that to change this year. Furthermore we have yet to see the benefits of a hardeningΒ ofΒ insuranceΒ rates in theΒ market.Β Β Despite these external factors,Β the overall growth in our revenues and profitsΒ highlights the resilience of the business. However, I do expect the economic downturn to continue into next year and this will present fresh challenges to both ourΒ clients and the Group which will have to be addressed."
Enquiries:
| Jelf Group plcAlex Alway, Group Chief ExecutiveJohn Harding, Group Finance and Operations Director | 01454 272 7130117 315 6563 |
| Cenkos Securities plc Stephen KeysJulian Morse | 020 7397 8926020 7397 1931 |
Notes to Editors:
Jelf Group was founded byΒ Chris JelfΒ in 1989. Today, the Jelf Group operates from a number of premises inΒ EnglandΒ &Β WalesΒ and offers an extensive range of corporate and private client services;
The Group advises in excess of 40,000 corporate clients across a range of disciplines. These clients cover the spectrum from significant public companies to small owner-managed businesses. Core Jelf clients are medium-sized owner-managed businesses.
The Group has continued to strengthen its corporate support infrastructure and integrate the acquisitions made.Β
Further information is available on Jelf Group at the Group's website:Β www.jelfgroup.com.
Chairman's statement
Our strategy continues to be one of expanding the business through offering a broad range of services to new and existing clients. TheΒ range of services which we offer to owner-managed businesses, in particular, hasΒ enabledΒ the Group to maintain its resilience even within a challenging economic environment.
We continue to successfully integrate key acquisitions, and we are pleased with the performance of these businesses given the wider economic climate. TheΒ contribution of these acquisitions to ourΒ insurance and employee benefitsΒ businessesΒ continuesΒ to be in line with forecasts.Β
Our organic growth (ex-acquisitions) has declined in the first half as a result of the economic downturn, which has affected all our businesses in varying degrees. We achieved positive organic growth in Employee Benefits and Commercial Finance, but Insurance and in particular Wealth Management experienced negative organic growth due to the difficult economic and investment climate. Our overall organic growth was negative (-6%), but remained largely flat excluding Wealth Management.
Given the economic climate, we haveΒ continued toΒ focus on reducingΒ ourΒ cost baseΒ andΒ improvingΒ operating efficiencies during this period; these efforts will continue.
Our operating cash flow remains strong, which has helped us to reduce our total debt (bank plus deferred consideration) in the first half from Β£49.3m to Β£42.3m (-Β£7.0m or -14%).
The results of the Group are biased to the key months of the third quarter of our financial year due to the start of the tax year in April, when a significant amount of business is conducted. The interim results reflect this bias.Β
We would like to put on record our thanks for the continued support, dedication and professionalism of our staff. They continue to face considerable change within the business and constantly rise to the challenge.
I wouldΒ alsoΒ like to record our thanks to Bruce Carnegie-Brown,Β who retired from the Board in April 2009 following the acquisition ofΒ 3i QPE by the wider 3i Group.Β Bruce has made a valuable contribution to the Group in the last year, and we wish him well for the future.
TheΒ Board remains committed toΒ providing excellent service to our clients, and toΒ achievingΒ strong returnsΒ for our shareholders.
David Walker
Group Chairman
18th June 2009
Group Chief Executive's Statement
I amΒ pleased to beΒ in a position to report another set of solid results for the Group helped particularly by the successful integration of the three large acquisitions made last year. The economic climate is extremely challenging and the GroupΒ is takingΒ appropriate action to reduce its cost base to reflect thisΒ situation.Β
We continue to make investments in people and infrastructure, to enable the business to execute our declared growth strategy.
Financial performance
In the six-month period ending 31 March 2009, the Group increased its turnover by 40% to Β£35.0m (2008: Β£25.0m);Β Operating profit has decreased from Β£1.6m to a loss of Β£0.4mΒ due to the impact of restructuring costs and increased amortisation;Β EBITDAE increased byΒ 11% to Β£3.5m (2008:Β Β£3.1m).
Underlying EBITDAE margin was downΒ 17% to 10% (2008: 12%).
Cash generated from operations was Β£8.3m. Performance-based deferred consideration payments on previous acquisitions amounted to Β£3.6m for the period. Our deferred consideration liabilities have beenΒ reduced during the period from Β£26.1m as at 30 September 2008 to an estimated Β£18.5m, due to payments and the impact of earn-out formulae.
Total bank debt, gross of capitalised loan fees,Β isΒ nowΒ Β£24.3m. This increased from Β£23.5m as at 30 September 2008, with additional borrowings being used to help fund the payment of the deferred consideration. This is in line with expectations.
Organisational development
We have selectively investedΒ in the Group's infrastructure in this period to enable integration whilst reducing back office costs. Infrastructure investment in technology and front-line support will always be a priority.
We have largely completed the process of migration of the core Healthcare business ontoΒ oneΒ system.Β
Business Development
Insurance
Despite rating increasesΒ inΒ some elements of the market, the mid-to-large corporate market continues to be competitive due to a mixture of competition and the wider economic climate. The smaller owner-managed sector, where Jelf specialises, is less sensitive to incremental market rate movements and we have seen some rate increases here, but these have been offset by the difficultiesΒ faced byΒ many of our corporate clients and theΒ resultingΒ reduction of overall insurance covers. We anticipate that the challenging trading environment for our Insurance businesses will continue through 2009 and into the first half of 2010.
We have focused on reducing the cost base and theΒ integrationΒ of acquisitions during this period.
Despite these mixed market conditions, our client-focused approach has enabled us toΒ maintain strongΒ retentionΒ ratesΒ and to add value for clients.Β
Employee Benefits
The market for advice onΒ EmployeeΒ Benefits remains resilient and the Group continues to enjoy a strong competitive position in this area. Clients continue to seek good advice, however theΒ conversion ofΒ pipeline prospects for corporate pensions is taking longer to materialise as the decision making process is slowed due to focus on other areas such as redundancies.Β
TheΒ rates forΒ private medical insuranceΒ continueΒ toΒ hardenΒ and we are pleased to be able to reportΒ 13% organic growth on the previous year. The Group now places approximately Β£140m GWP annually in the private medical insurance market.
The results of the Healthcare business are weighted towards the second half of the financial year.Β
During this period we have worked hard at getting closer to our Healthcare corporate clients to introduce the widerΒ suite ofΒ employee benefits services and products and this campaign is beginning to bolster the pipeline of future prospects.
Wealth Management
The market for independent advice to individuals has been extremely difficult in the current economic environment. Revenues have fallen byΒ justΒ 5%,Β due to the addition ofΒ the threeΒ acquisitions made last year, all of which hadΒ smallΒ elements of financial services business. AllΒ areas of adviceΒ areΒ down as client confidenceΒ in this marketΒ has ebbed.Β
During this period we have reduced ourΒ cost base resulting in the release of a number of advisors and associated support staff. It is our intention to continue with the programme of integration and to focus on a smaller number of talented individuals whilst reducing costs further.Β
The business assurance campaign launched in 2008 has provided significant organic sales into the Group's existing corporate clients that have underpinned these results. This will continue to be a primary focus throughout 2009.
The Group now has currently circa Β£270m (2008: Β£200m) in third-party funds on Wrap programmes producing fund-based income. Despite a strong inflow of funds, the overall amount under advice has reduced in line with equity price movements and remains market sensitive. In addition we continue to advise on over Β£1 billion of client funds under advice in old style product structures.
It is unlikely that we will see any return of confidence to this market during 2009Β and the first half of 2010.
Acquisitions
Whilst the Group has a healthy pipeline ofΒ potentialΒ acquisitions it has chosen not to invest during this period due to a lack of value. The consolidation of the intermediary market whilst slowing in pace has continued despite the wider economic difficulties.
The Insurance and Healthcare elements of the acquisitions made in 2008 are trading in line with expectations. These businesses did contain some Wealth Management businesses which although small in size are trading below expectations.Β
People
I am particularly pleased at the progress made this year in the way the management and employees of the businesses acquired in 2008 have embraced the opportunities within the wider Group and are making a real contribution.
Whilst we have not made any acquisitions during this period and will have a strong focus onΒ operating efficiencies,Β we have continued to recruit and motivate key talent whilst strengthening the senior management team with appointments and promotions.
Our employees and management continue to deliver excellent value to our clients, shareholders and our strategic partners in the market. They remain our key asset.
Future
The Group will continue with its strategy of strengthening its position within its chosen sectors and providing a wider range of enhanced services to our clients.
The Jelf GroupΒ will continueΒ to place great emphasis onΒ superiorΒ customer serviceΒ to our clients .
Alex Alway
Group Chief Executive
18thΒ June 2009
ConsolidatedΒ Balance Sheet
|
Note |
31 Mar 2009Β (unaudited) |
31 MarΒ 2008Β (unaudited) |
30 Sept 2008 Β (audited) |
||||
|
Β |
Β |
Β |
Β |
Β |
Β£'000 |
Β£'000 |
Β£'000 |
|
Non-current assets |
|||||||
|
Goodwill |
69,786 |
46,086 |
73,972 |
||||
|
Intangible assets |
53,890 |
37,171 |
56,180 |
||||
|
Property, plant and equipment |
3,173 |
2,471 |
3,160 |
||||
|
Available for sale investments |
Β |
Β |
83 |
143 |
76 |
||
|
126,932 |
85,871 |
133,388 |
|||||
|
Current assets |
|||||||
|
Trade and other receivables |
15,214 |
10,014 |
14,289 |
||||
|
Cash and cash equivalentsΒ 1 |
24,791 |
32,538 |
21,832 |
||||
|
Derivative financial instruments |
Β |
Β |
- |
61 |
- |
||
|
40,005 |
42,613 |
36,121 |
|||||
|
Total assets |
Β |
Β |
Β |
166,937 |
128,484 |
169,509 |
|
|
Current liabilities |
|||||||
|
Short-term provisions |
(1,353) |
(152) |
(775) |
||||
|
Deferred income tax liability |
(1,284) |
(838) |
(1,272) |
||||
|
Trade and other payables |
(31,384) |
(16,577) |
(26,101) |
||||
|
Deferred consideration |
(13,212) |
(10,354) |
(13,578) |
||||
|
Income tax liabilities |
Β |
Β |
Β |
(2,515) |
(972) |
(2,670) |
|
|
Derivative financial liabilities |
(1,273) |
- |
(14) |
||||
|
Bank loans |
Β |
Β |
Β |
(498) |
- |
(498) |
|
|
(51,519) |
(28,893) |
(44,908) |
|||||
|
Net currentΒ (liabilities)Β /Β assets |
(11,514) |
13,720 |
(8,787) |
||||
|
Non-current liabilities |
|||||||
|
Long-term provisions |
(223) |
(109) |
(254) |
||||
|
Deferred income tax liability |
(12,364) |
(10,461) |
(13,686) |
||||
|
Trade and other payables |
(24) |
(181) |
(46) |
||||
|
Deferred consideration |
(5,330) |
(6,144) |
(12,513) |
||||
|
Bank loans |
(23,296) |
(10,144) |
(22,663) |
||||
|
(41,237) |
(27,039) |
(49,162) |
|||||
|
Total liabilities |
Β |
Β |
Β |
(92,756) |
(55,932) |
(94,070) |
|
|
Net assets |
Β |
Β |
Β |
Β |
74,181 |
72,552 |
75,439 |
|
Equity |
|||||||
|
Share capital |
5,6 |
498 |
498 |
498 |
|||
|
Share premium |
6 |
54,850 |
54,875 |
54,850 |
|||
|
Merger reserve |
10,742 |
10,742 |
10,742 |
||||
|
Other reserves |
6 |
448 |
(387) |
712 |
|||
|
Retained earnings |
6 |
7,643 |
6,824 |
8,637 |
|||
|
Total equity |
Β |
Β |
Β |
74,181 |
72,552 |
75,439 |
|
1 Included within cash and cash equivalents is fiduciary cash of Β£18,951,000Β (31 March 2008: Β£12,837,000; 30 September 2008: Β£18,161,000).
The notes on pagesΒ 10Β toΒ 14Β form an integral part of theseΒ condensed interim financial statements.
Consolidated income statement
|
Note |
Six months endedΒ 31 Mar 2009 (unaudited) |
Six months endedΒ 31 Mar 200 Β (unaudited) |
YearΒ endedΒ 30 Sept 2008Β (audited) |
||||||
|
Β |
Β |
Β |
Β |
Β |
Β |
Β£'000 |
Β£'000 |
Β£'000 |
|
|
Revenue |
35,019 |
25,024 |
63,147 |
||||||
|
Cost of Sales |
Β |
Β |
Β |
Β |
(2,195) |
(2,036) |
(4,758) |
||
|
Gross Profit |
32,824 |
22,988 |
58,389 |
||||||
|
Administrative expenses |
Β |
Β |
Β |
(33,253) |
(21,399) |
(53,308) |
|||
|
OperatingΒ (loss) /Β profit |
(429) |
1,589 |
5,081 |
||||||
|
OperatingΒ (loss) /Β profit consists of: |
|||||||||
|
Earnings before interest, taxation, depreciation,Β amortisationΒ andΒ exceptional (EBITDAE) |
3,450 |
3,110 |
10,066 |
||||||
|
Group reorganisation and rationalisation costs |
8 |
(1,099) |
- |
(666) |
|||||
|
Depreciation ofΒ property, plant and equipment |
(432) |
(317) |
(738) |
||||||
|
Amortisation of intangibleΒ assets |
Β |
Β |
(2,348) |
(1,204) |
(3,581) |
||||
|
Investment revenues |
30 |
153 |
308 |
||||||
|
Finance costs |
Β |
Β |
Β |
Β |
(965) |
(1,004) |
(1,875) |
||
|
(Loss) / Profit before income tax |
(1,364) |
738 |
3,514 |
||||||
|
Income taxΒ credit / (expense) |
Β |
Β |
Β |
370 |
(118) |
(1,081) |
|||
|
Β (Loss) / profit for the period |
Β |
Β |
(994) |
620 |
2,433 |
||||
|
Β |
Β |
Β |
Β |
Β |
Β |
||||
|
(Loss) /Β earnings per shareΒ attributable to equity holders of the Company |
|||||||||
|
Basic (pence) |
4 |
(2.0) |
2.0 |
6.1 |
|||||
|
Diluted (pence) |
Β |
Β |
Β |
4 |
(2.0) |
1.9 |
6.0 |
||
All results are derived from continuing operationsΒ
Consolidated statement of recognised income and expense
|
Six monthsΒ endedΒ 31 Mar 2009Β (unaudited) |
Six months endedΒ 31 MarΒ 2008 (unaudited) |
YearΒ endedΒ 30 Sept 2008Β (audited) |
||||||
|
Β |
Β |
Β |
Β |
Β |
Β |
Β£'000 |
Β£'000 |
Β£'000 |
|
(Loss) / gain on cash flow hedgesΒ (net of tax) |
Β |
Β |
(903) |
61 |
(14) |
|||
|
Net (loss) / income recognised directly in equity |
(903) |
61 |
(14) |
|||||
|
(Loss) / profit for the period |
(994) |
620 |
2,433 |
|||||
|
Total recognised income and expense for the period |
(1,897) |
681 |
2,419 |
|||||
Consolidated cash flow statement
|
Note |
Six months endedΒ 31 Mar 2009 (unaudited) |
Six months endedΒ 31 Mar 2008(restated andΒ unaudited) |
YearΒ endedΒ 30 Sept 2008(audited) |
|||
|
Β |
Β |
Β |
Β |
Β£'000 |
Β£'000 |
Β£'000 |
|
Cash flows from operating activities |
||||||
|
Cash generated from operations |
7 |
8,345 |
6,471 |
10,538 |
||
|
Interest paid |
(1,003) |
(872) |
(1,642) |
|||
|
Taxation paid |
(778) |
(3,146) |
(2,817) |
|||
|
Net cashΒ flowΒ from operating activities |
Β |
Β |
6,564 |
2,453 |
6,079 |
|
|
Cash flows from investing activities |
||||||
|
Interest received |
29 |
193 |
276 |
|||
|
Proceeds on disposal of property, plant and equipment |
14 |
- |
- |
|||
|
Purchase of property, plant and equipment |
(458) |
(467) |
(892) |
|||
|
Purchase of intangible assets |
(57) |
(174) |
(279) |
|||
|
Purchase of own shares |
(91) |
(695) |
(725) |
|||
|
Acquisition of subsidiaries and businessesΒ 1 |
25 |
(12,135) |
(35,354) |
|||
|
Deferred consideration paidΒ 2 |
(3,609) |
(985) |
(4,724) |
|||
|
Net cashΒ flowΒ used in investing activities |
Β |
Β |
(4,147) |
(14,263) |
(41,698) |
|
|
Cash flows from financing activities |
||||||
|
Repayments of bank loans |
- |
(23,870) |
(23,870) |
|||
|
Repayments of obligations under finance leases |
(31) |
- |
(43) |
|||
|
Proceeds on issue of shares (net of expenses) |
- |
44,994 |
44,994 |
|||
|
AdditionalΒ bank loans raised (net of expenses) |
Β |
Β |
573 |
13,954 |
27,100 |
|
|
Net cash flow from financing activities |
Β |
Β |
542 |
35,078 |
48,181 |
|
|
Net increase in cash and cash equivalents |
2,959 |
23,268 |
12,562 |
|||
|
Cash and cash equivalents at beginning of period |
21,832 |
9,270 |
9,270 |
|||
|
Cash and cash equivalents at end of periodΒ 3 |
Β |
24,791 |
32,538 |
21,832 |
||
1 Cash inflow fromΒ theΒ acquisition of subsidiaries and businesses for the six months ended 31 Mar 2009 has been shown net of Β£63,000Β receiptΒ relating to a net asset settlement on a previous acquisition. 2 The condensed interim financial statements for the six months ended 31 March 2008 disclosed deferred consideration paid asΒ a financing activity. This has subsequently been restated to be an investing activity.3 Included within cash and cash equivalents is fiduciary cash of Β£18,951,000Β (31 March 2008: Β£12,837,000; 30 September 2008: Β£18,161,000).
1. General information
Jelf Group plc is an AIM listedΒ company incorporated in theΒ United KingdomΒ under the Companies Act 1985. The address of the registeredΒ office is given in noteΒ 9.
These condensed interim financial statements do not comprise statutory accounts under the meaning of Section 240 of the Companies Act 1985Β andΒ should be read in conjunction with the statutory accounts for the year ended 30Β SeptemberΒ 2008. These wereΒ prepared underΒ International Financial Reporting Standards (IFRSs),Β whichΒ were approved by the Board of Directors onΒ 2 February 2009Β and delivered to the Registrar of Companies. The report of the auditors on those accounts was unqualified, did not contain an emphasis of matter paragraph and did not contain any statement under Section 237 (2) or (3) of the Companies Act 1985.
These financial statements are presented in pounds sterling because that is the currency of the primary economic environment in which the Group operates.
2. Basis of preparation
The condensed financial statements have been prepared using accounting policies consistent withΒ IFRSsΒ as adopted for use in the European UnionΒ and the AIM rulesΒ and as disclosed in the Group's statutory accounts for the year ended 30 September 2008. These condensed financial statements do not comply with all the requirements of IAS 34 'Interim financial reporting' as the Company is not required to adopt this.
The statutory accounts for the year ended 30 September 2008 were the Group's first under IFRS and the reserves at 1 October 2007 have been restated accordingly.
The Group has applied s131 of the Companies Act 1985 in respect of merger relief. An adjustment in respect of this has been made to the equity reserves at 31 March 2008 and the relevant balances restated.
3. Segmental Reporting
TheΒ Board have determined that theΒ Group hasΒ five business sectors: Insurance, Healthcare, EmployeeΒ Benefits,Β CommercialΒ Finance andΒ WealthΒ Management. Business sector data includes an allocation of corporate costs toΒ eachΒ sector. There are no sales between business sectors.
All turnover arose within theΒ United Kingdom. No secondary segment information is therefore given. SegmentΒ informationΒ about these businesses is presented below.
|
Six monthsΒ endedΒ 31 Mar 2009 (unaudited) |
Six monthsΒ endedΒ 31 Mar 2008 (unaudited) |
Year endedΒ 30 Sept 2008 Β (audited) |
||
|
Β |
Β |
Β£'000 |
Β£'000 |
Β£'000 |
|
Revenue |
||||
|
Insurance |
22,641 |
13,824Β |
35,852 |
|
|
Healthcare |
4,905 |
3,664Β |
9,796 |
|
|
Employee benefits |
3,112 |
3,024Β |
7,842 |
|
|
Commercial finance |
317 |
268Β |
627 |
|
|
Wealth management |
4,044 |
4,244Β |
9,030 |
|
|
Β |
Β |
35,019 |
25,024Β |
63,147 |
|
Six months endedΒ 31 Mar 2009 (unaudited) |
Six monthsΒ endedΒ 31 Mar 2008 (unaudited) |
Year endedΒ 30 Sept 2008 (audited) |
||||
|
Β |
Β |
Β£'000 |
Β£'000 |
Β£'000 |
||
|
(Loss) /Β profitΒ for the period |
||||||
|
Insurance |
3,479 |
2,506Β |
6,173 |
|||
|
Healthcare |
814 |
181Β |
2,382 |
|||
|
Employee benefits |
(319) |
152Β |
961 |
|||
|
Commercial finance |
(111) |
(47) |
2 |
|||
|
Wealth management |
Β |
(413) |
318Β |
548 |
||
|
Earnings before interest, taxation, depreciation, amortisation andΒ exceptional (EBITDAE) |
3,450 |
3,110Β |
10,066 |
|||
|
Group reorganisation and rationalisation costs |
(1,099) |
- |
(666) |
|||
|
Depreciation of tangible fixed assets |
(432) |
(317) |
(738) |
|||
|
Amortisation of intangible fixed assets |
(2,348) |
(1,204) |
(3,581) |
|||
|
Investment revenues |
30 |
153Β |
308 |
|||
|
Finance costs |
(965) |
(1,004) |
(1,875) |
|||
|
Income taxΒ credit / (expense) |
370 |
(118) |
(1,081) |
|||
|
(Loss) / profit for the period |
(994) |
620 |
2,433 |
|||
|
Balance sheet |
||||||
|
TotalΒ assets |
||||||
|
Insurance |
114,890 |
61,559 |
118,906 |
|||
|
Healthcare |
28,185 |
25,999 |
25,595 |
|||
|
Employee benefits |
4,304 |
7,671 |
6,781 |
|||
|
Commercial finance |
694 |
181 |
661 |
|||
|
Wealth management |
15,236 |
15,060 |
15,843 |
|||
|
Unallocated |
3,628 |
18,014 |
1,723 |
|||
|
166,937 |
128,484 |
169,509 |
||||
|
TotalΒ liabilities |
||||||
|
Insurance |
(65,437) |
(32,004) |
(58,102) |
|||
|
Healthcare |
(23,438) |
(12,976) |
(22,404) |
|||
|
Employee benefits |
(1,371) |
(3,476) |
(3,253) |
|||
|
Commercial finance |
(94) |
(532) |
(3,021) |
|||
|
Wealth management |
(2,416) |
(6,944) |
(7,290) |
|||
|
(92,756) |
(55,932)Β |
(94,070) |
||||
|
Other information |
||||||
|
Capital additions |
||||||
|
Insurance |
107 |
67 |
517 |
|||
|
Healthcare |
7 |
154 |
161 |
|||
|
Employee benefits |
186 |
108 |
79 |
|||
|
Commercial finance |
- |
- |
14 |
|||
|
Wealth management |
237 |
204 |
132 |
|||
|
Β |
Β |
537 |
533 |
903 |
||
|
Six monthsΒ endedΒ 31 Mar 2009Β (unaudited) |
Six monthsΒ endedΒ 31 Mar 2008 (unaudited) |
YearΒ endedΒ 30 Sept 2008 (audited) |
||||
|
Β |
Β |
Β£'000 |
Β£'000 |
Β£'000 |
||
|
Other information |
||||||
|
Depreciation |
||||||
|
Insurance |
196 |
143 |
380 |
|||
|
Healthcare |
36 |
36 |
75 |
|||
|
Employee benefits |
84 |
47 |
101 |
|||
|
Commercial finance |
2 |
3 |
4 |
|||
|
Wealth management |
114 |
88 |
178 |
|||
|
Β |
Β |
432 |
317 |
738 |
||
|
Amortisation |
||||||
|
Insurance |
1,753 |
829 |
2,677 |
|||
|
Healthcare |
356 |
271 |
517 |
|||
|
Employee benefits |
54 |
6 |
75 |
|||
|
Commercial finance |
- |
- |
1 |
|||
|
Wealth management |
185 |
98 |
311 |
|||
|
Β |
Β |
2,348 |
1,204 |
3,581 |
||
4. (Loss) / earnings per share
(Loss) / earnings per share attributable to the equity holders of the Company are as follows:-
|
Six months endedΒ 31 Mar 2009 (unaudited) |
Six monthsΒ endedΒ 31 Mar 2008Β (unaudited) |
YearΒ endedΒ 30 Sept 2008Β (audited) |
|||
|
(Loss) /Β profit for the period (Β£'000) |
(994) |
620 |
2,433 |
||
|
AmortisationΒ and exceptionalsΒ (net of tax) (Β£'000) |
2,212 |
1,204 |
3,088 |
||
|
Underlying profit for the period (Β£'000)1 |
1,218 |
1,824 |
5,521 |
||
|
Weighted average shares in issueΒ |
|||||
|
(number) |
Basic |
49,099,240 |
30,580,433 |
39,608,301 |
|
|
Β |
Diluted |
Β |
49,341,872 |
32,688,794 |
40,385,502 |
|
(Loss) / earnings per shareΒ |
|||||
|
(pence) |
Basic |
(2.0) |
2.0 |
6.1 |
|
|
Β |
Diluted2 |
(2.0) |
1.9 |
6.0 |
|
|
Amortisation and exceptional per shareΒ |
|||||
|
(pence) |
Basic |
4.5 |
4.0 |
7.8 |
|
|
DilutedΒ |
4.5 |
3.7 |
7.6 |
||
|
Underlying earnings per share1 |
|||||
|
(pence) |
BasicΒ |
2.5 |
6.0 |
13.9 |
|
|
Β |
DilutedΒ |
2.5 |
5.6 |
13.7 |
|
1. before deduction of amortisation of intangible fixed assetsΒ andΒ exceptional
2. in accordance with IAS33 Earnings per Share, the basic weighted average shares in issue has been used toΒ calculate theΒ 2009 loss per share due to the antidilutive nature of losses
5. Share capital
As at 31 March 2009Β the Company had authorised share capital of 100,000,000 (31 March and 30 September 2008: 100,000,000) ordinary shares of 1p each, of whichΒ 49,802,687Β (31 March 2008:Β 49,787,906, 30 September 2008:Β 49,802,687) ordinary shares have been allotted, called up and fully paid.
At 31 March 2009, of the called up share capital,Β 780,968Β (31 March 2008:Β 423,809, 30 September 2008:Β 785,609) ordinary shares were held by the Jelf Group plc Employee Benefit Trust and are shown within other reserves.
On 25 February 2008 22,117,648 new ordinary shares of 1p each were issued for Β£45.0m, net of share issue costs, and admitted to AIM. The new ordinary shares will rank pari passu with the existing ordinary shares of the Company.
|
6. Statement of changesΒ in equity |
|||||||||
|
ShareΒ capital |
ShareΒ premium |
Merger reserve |
HedgingΒ reserve1,2 |
Share based payment reserve1 |
Own shares held1 |
Other reserves1 |
Profit and loss account |
Total Equity |
|
|
Β |
Β£'000 |
Β£'000 |
Β£'000 |
Β£'000 |
Β£'000 |
Β£'000 |
Β£'000 |
Β£'000 |
Β£'000 |
|
At 1 October 2007 (restatedΒ and audited) |
257Β |
10,103 |
6,144 |
-Β |
757Β |
(851) |
14 |
6,204Β |
22,628 |
|
Share based payments |
- |
- |
- |
- |
327Β |
- |
- |
327 |
|
|
Share issue (net of issue costs) |
241Β |
44,772 |
4,598 |
- |
- |
- |
- |
- |
49,611 |
|
Purchase of own shares by EBT |
- |
- |
- |
- |
- |
(695) |
- |
- |
(695) |
|
Unrealised gain on cash flow hedges |
- |
- |
- |
61Β |
- |
- |
- |
- |
61 |
|
Profit for the period |
- |
- |
- |
- |
- |
- |
- |
620 |
620 |
|
At 31 March 2008 (unaudited) |
498Β |
54,875 |
10,742 |
61Β |
1,084Β |
(1,546) |
14 |
6,824 |
72,552 |
|
Share based payments |
- |
- |
- |
- |
1,204 |
- |
- |
- |
1,204 |
|
Share issue costs |
- |
(25) |
- |
- |
- |
- |
- |
- |
(25)Β |
|
Purchase of own shares by EBT |
- |
- |
- |
- |
- |
(30) |
- |
- |
(30) |
|
Unrealised loss on cash flow hedges |
- |
- |
- |
(75) |
- |
- |
- |
- |
(75) |
|
Profit for the period |
- |
- |
- |
- |
- |
- |
- |
1,813 |
1,813 |
|
At 30 September 2008Β (audited) |
498 |
54,850 |
10,742 |
(14) |
2,288 |
(1,576) |
14 |
8,637 |
75,439 |
|
Share based payments |
- |
- |
- |
- |
730 |
- |
- |
- |
730 |
|
Purchase of own shares by EBT |
- |
- |
- |
- |
- |
(91) |
- |
- |
(91) |
|
Unrealised lossΒ on cash flow hedges |
- |
- |
- |
(903) |
- |
- |
- |
- |
(903) |
|
LossΒ for the period |
- |
- |
- |
- |
- |
- |
- |
(994) |
(994) |
|
At 31 March 2009 (unaudited) |
498 |
54,850 |
10,742 |
(917) |
3,018 |
(1,667) |
14 |
7,643 |
74,181 |
1 shown within other reserves on the balance sheet
2 shown net of tax
|
7. Cash generated from operations |
|||||
|
Six monthsΒ endedΒ 31 Mar 2009 (unaudited) |
Six months endedΒ 31 Mar 2008 (unaudited) |
YearΒ endedΒ 30 Sept 2008 (audited) |
|||
|
Β |
Β |
Β |
Β£'000 |
Β£'000 |
Β£'000 |
|
(Loss) / profit for the period |
(994) |
620 |
2,433 |
||
|
Adjustments for: |
|||||
|
Investment revenues |
(30) |
Β (153) |
(308) |
||
|
Finance costs |
965 |
1,004Β |
1,875 |
||
|
Income taxΒ (credit) / expense |
(370) |
118Β |
1,081 |
||
|
Depreciation of property, plant and equipment |
432 |
317 |
738 |
||
|
Amortisation of intangible assets |
2,348 |
1,204Β |
3,581 |
||
|
Share-based payment expense |
730 |
327Β |
1,069 |
||
|
Capitalised share-based payments |
- |
- |
461 |
||
|
Increase in provisions |
547 |
12 |
862 |
||
|
Operating cash flows before movement in working capital |
3,628 |
3,449 |
11,792 |
||
|
Increase in receivables |
(992) |
(6,641) |
(172) |
||
|
IncreaseΒ / (decrease)Β in payables |
5,709 |
9,663 |
(1,082) |
||
|
Cash generatedΒ fromΒ operations |
Β |
8,345 |
6,471Β |
10,538 |
|
8. Exceptional costs
Β£1,099,000 (31 March 2008: Β£nil, 30 September 2008: Β£666,000) of Group reorganisation and rationalisation costs are a result of combining and restructuring operations. These costs are not associated with the ongoing activities of the Group.
9. Copies of the Interim Financial Statements
Copies ofΒ this Interim Report and AccountsΒ announcementΒ are available on the Group's websiteΒ (www.jelfgroup.com) or from the Company Secretary at the Company's registered office: Fromeforde House,Β Church Road, Yate,Β Bristol,Β BS37 5JB.
Follow the stocks